Department of Psychiatry
Penn Behavioral Health

Stanley N. Caroff

faculty photo

Stanley N. Caroff

Emeritus Professor CE of Psychiatry
Department: Psychiatry

Contact information
Psychiatry Service (116A)
Philadelphia VA Medical Center
University and Woodland Avenues
Philadelphia, PA 19104
Office: 2158234066
Fax: 2158234610
B.A. (Anthropology)
Columbia University, 1971.
M.D. (Medicine)
Mount Sinai Medical School, 1975.
Post-Graduate Training
Intern in Medicine, Roosevelt Hospital, New York, NY., 1975-1976.
Resident in Psychiatry, State University of New York at Stony Brook, New York., 1976-1977.
Resident in Psychiatry, Montefiore Hospital, New York, NY., 1978-1979.
Postdoctoral Trainee and Fellow in Psychiatry, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA., 1979-1981.
Permanent link

Description of Research Expertise

Neuroleptic malignant syndrome,
Tardive dyskinesia
Antipsychotic pharmacology
Drug-induced hyperthermic disorders

Description of Clinical Expertise

Neuroleptic malignant syndrome,
Tardive dyskinesia
Antipsychotic pharmacology
Drug-induced hyperthermic disorders

Selected Publications

Caroff SN, Hurford I, Bleier HR, Gorton GE, Campbell EC: Recurrent idiopathic catatonia: implications beyond DSM 5. Clinical Psychopharmacol Neurosci in press,, 2015.

Caroff SN, Campbell EC: Risk of neuroleptic malignant syndrome in patients with NMDAR encephalitis. Neurol Sci 36(3): 479-480, 2015.

Caroff SN, Mann SC, Campbell EC: Neuroleptic malignant syndrome and the catatonic dilemma. Psychopharmacology (Berl) 232(3): 661-662, 2015.

Ungvari GS, Mann SC, Caroff SN: An outline of historical and clinical aspects of catatonic schizophrenia. Curr Psychiatr Rev 9: 94-100, 2013.

Caroff Stanley N, Davis Vicki G, Miller Del D, Davis Sonia M, Rosenheck Robert A, McEvoy Joseph P, Campbell E Cabrina, Saltz Bruce L, Riggio Silvana, Chakos Miranda H, Swartz Marvin S, Keefe Richard S E, Stroup T Scott, Lieberman Jeffrey A, : Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia. The Journal of clinical psychiatry 72(3): 295-303, Mar 2011.

Campbell E Cabrina, DeJesus Melissa, Herman Barry K, Cuffel Brian J, Sanders Kafi N, Dodge William, Dhopesh Vasant, Caroff Stanley N: A pilot study of antipsychotic prescribing decisions for acutely-Ill hospitalized patients. Progress in neuro-psychopharmacology & biological psychiatry 35(1): 246-51, Jan 2011.

Caroff Stanley N, Hurford Irene, Lybrand Janice, Campbell E Cabrina: Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial. Neurologic clinics 29(1): 127-48, viii, Feb 2011.

Caroff SN, Miller DD, Rosenheck RA: Extrapyramidal side effects. The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial:How does it inform practice, policy, and research? Stroup TS, Lieberman JA (eds.). Cambridge University Press, Page: 156-172, 2010.

Aberg K, Adkins DE, Bukszar J, Webb BT, Caroff SN, Miller DD, Sebat J, Stroup S, Fanous AH, Vladimirov VI, McClay JL, Lieberman JA, Sullivan PF, van den Oord EJCG. : Genome-wide association study of movement-related adverse antipsychotic effects. Biol Psychiatry 67: 279-282, 2010.

Caroff SN, Martine R, Kleiner-Fisman G, Eisa M, Stern MB, Duda JE: Treatment of levodopa-induced dyskinesias with donepezil. World Parkinson Congress, Washnigton DC, February 22-26, 2006 2006.

Caroff SN, Campbell EC, Walker P, Lorry A, Petro C, Lynch K, Gallop R: Traetment of tardive dyskinesia with galantamine. Institute of Psychiatric Service, New York, NY 2006.

Strawn JR, Keck PE Jr, Caroff SN: Neuroleptic malignant syndrome. Am J Psychiatry 164: 870-876, 2007.

Satterthwaite TD, Wolf DH, Rosenheck RA, Gur RE, Caroff SN: A meta-analysis of the risk risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation. J Clin Psychiatry 69: 1869-1879, 2008.

Miller DD, Caroff SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL, Swartz MS, Keefe RSE, Stroup TS, Lieberman JA: Extrapyramidal Side Effects of Antipsychotics in a Randomized Trial: Findings from the CATIE Schizophrenia Trial. Br J Psychiatry 193: 279-288, 2008.

Lybrand J, Caroff SN: Management of schizophrenia with substance use disorders. Psychiatr Clin N Am 32: 821-833, 2009.

Tsai HT, Caroff SN, Miller DD, McEvoy J, Lieberman J, North K, Stroup TS, Sullivan PF. : A candidate gene study of tardive dyskinesia in the CATIE schizophrenia trial. Am J Med Genetics B: Neuropsychiatric Genetics 5(153B): 336-340, 2010.

Ungvari GS, Caroff SN, Gerevich J: The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull 36: 231-238, 2010.

Gazdag G, Mann SC, Ungvari GS, Caroff SN: Clinical evidence for the efficacy of ECT in the treatment of catatonia and psychoses. Electroconvulsive and Neuromodulation Therapy, Swartz C (eds.). Cambridge University Press, 2009.

back to top
Last updated: 10/06/2015
The Trustees of the University of Pennsylvania